-
Share
790 Posts.
144
01/07/13
15:31
Share
Saverio,
that was after 5 days but then the virus levels rose again by the 20th day.
This is not a trend that looks attractive to me.
It is obvious to me that another HIV trial would need to be commissioned using bit2225 in a 90 day trial with the current standard of care drugs.
The question is whether a pharma would be willing to pay for this access at this point in time with the limited evidence we have.
-
